Rac1 signaling modulates BCL-6-mediated repression of gene transcription

Molecular and Cellular Biology

Volumn 29, Issue 15, 2009, Pages 4156-4166

  Barros, Patrícia ^a   Jordan, Peter ^a   Matos, Paulo ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; P21 ACTIVATED KINASE 1; PROTEIN BCL 6; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL LINE; CELLULAR DISTRIBUTION; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; GENE ACTIVITY; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AMINOQUINOLINES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NF-KAPPA B P50 SUBUNIT; P21-ACTIVATED KINASES; PROTEIN BINDING; PYRIMIDINES; RAC1 GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 67651204601     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01813-08     Document Type: Article

References (73)

1. Allman, D., A. Jain, A. Dent, R. R. Maile, T. Selvaggi, M. R. Kehry, and L. M. Staudt. 1996. BCL-6 expression during B-cell activation. Blood 87:5257-5268.
2. Baer, M., A. Dillner, R. C. Schwartz, C. Sedon, S. Nedospasov, and P. F. Johnson. 1998. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-κB p50. Mol. Cell. Biol. 18:5678-5689.
3. Benitah, S. A., P. F. Valeron, L. van Aelst, C. J. Marshall, and J. C. Lacal. 2004. Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim. Biophys. Acta 1705:121-132.
4. Bereshchenko, O. R., W. Gu, and R. Dalla-Favera. 2002. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32:606-613.
5. Bonizzi, G., J. Piette, S. Schoonbroodt, R. Greimers, L. Havard, M. P. Merville, and V. Bours. 1999. Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity. Mol. Cell. Biol. 19:1950-1960.
6. Bos, J. L., H. Rehmann, and A. Wittinghofer. 2007. GEFs and GAPs: critical elements in the control of small G proteins. Cell 129:865-877.
7. Boureux, A., E. Vignal, S. Faure, and P. Fort. 2007. Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol. Biol. Evol. 24:203-216.
8. Boyer, L., S. Travaglione, L. Falzano, N. C. Gauthier, M. R. Popoff, E. Lemichez, C. Fiorentini, and A. Fabbri. 2004. Rac GTPase instructs nuclear factor-κB activation by conveying the SCF complex and IkBα to the ruffling membranes. Mol. Biol. Cell 15:1124-1133.
9. Cattoretti, G., C. C. Chang, K. Cechova, J. Zhang, B. H. Ye, B. Falini, D. C. Louie, K. Offit, R. S. Chaganti, and R. Dalla-Favera. 1995. BCL-6 protein is expressed in germinal-center B cells. Blood 86:45-53.
10. Chang, C. C., B. H. Ye, R. S. Chaganti, and R. Dalla-Favera. 1996. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA 93:6947-6952.
11. Cogswell, P. C., R. I. Scheinman, and A. S. Baldwin, Jr. 1993. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL. J. Immunol. 150:2794-2804.
12. Dalla-Favera, R., A. Migliazza, C. C. Chang, H. Niu, L. Pasqualucci, M. Butler, Q. Shen, and G. Cattoretti. 1999. Molecular pathogenesis of B cell malignancy: the role of BCL-6. Curr. Top. Microbiol. Immunol. 246:257-263.
13. Dent, A. L., F. H. Vasanwala, and L. M. Toney. 2002. Regulation of gene expression by the proto-oncogene BCL-6. Crit. Rev. Oncol. Hematol. 41:1-9.
14. DerMardirossian, C., and G. M. Bokoch. 2005. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15:356-363.
15. Dhordain, P., O. Albagli, N. Honore, F. Guidez, D. Lantoine, M. Schmid, H. D. The, A. Zelent, and M. H. Koken. 2000. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF. Oncogene 19:6240-6250.
16. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
17. Driessler, F., K. Venstrom, R. Sabat, K. Asadullah, and A. J. Schottelius. 2004. Molecular mechanisms of interleukin-10-mediated inhibition of NFkappaB activity: a role for p50. Clin. Exp. Immunol. 135:64-73.
18. Esufali, S., and B. Bapat. 2004. Cross-talk between Rac1 and dysregulated Wnt signaling pathway leads to cellular redistribution of β-catenin and TCF/LEF-mediated transcriptional activation. Oncogene 23:8260-8271.
19. Esufali, S., G. S. Charames, V. V. Pethe, P. Buongiorno, and B. Bapat. 2007. Activation of tumor-specific splice variant Rac1b by Dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells. Cancer Res. 67:2469-2479.
20. Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature 420:629-635.
21. Fiegen, D., L. C. Haeusler, L. Blumenstein, U. Herbrand, R. Dvorsky, I. R. Vetter, and M. R. Ahmadian. 2004. Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J. Biol. Chem. 279:4743-4749.
22. Fujita, T., G. P. Nolan, H. C. Liou, M. L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7:1354-1363.
23. Fukata, M., and K. Kaibuchi. 2001. Rho-family GTPases in cadherin-mediated cell-cell adhesion. Nat. Rev. Mol. Cell Biol. 2:887-897.
24. Gao, Y., J. B. Dickerson, F. Guo, J. Zheng, and Y. Zheng. 2004. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 101:7618-7623.
25. Gotley, D. C., J. Fawcett, M. D. Walsh, J. A. Reeder, D. L. Simmons, and T. M. Antalis. 1996. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br. J. Cancer 74:342-351.
26. Guan, H., S. Hou, and R. P. Ricciardi. 2005. DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J. Biol. Chem. 280:9957-9962.
27. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-513.
28. Hall, A. 2005. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 33:891-895.
29. Herrlich, P., S. Pals, and H. Ponta. 1995. CD44 in colon cancer. Eur. J. Cancer 31:1110-1112.
30. Huang, Y. C., W. C. Hung, W. Y. Kang, W. T. Chen, and C. Y. Chai. 2007. Expression of STAT3 and Bcl-6 oncoprotein in sodium arsenite-treated SV-40 immortalized human uroepithelial cells. Toxicol. Lett. 173:57-65.
31. Huynh, K. D., and V. J. Bardwell. 1998. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 17:2473-2484.
32. Huynh, K. D., W. Fischle, E. Verdin, and V. J. Bardwell. 2000. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14:1810-1823.
33. Jordan, P., R. Brazão, M. G. Boavida, C. Gespach, and E. Chastre. 1999. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18:6835-6839.
34. Kanazawa, N., M. Moriyama, T. Onizuka, K. Sugawara, and S. Mori. 1997. Expression of bcl-6 protein in normal skin and epidermal neoplasms. Pathol. Int. 47:600-607.
35. Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301-310.
36. Kawashima, T., Y. C. Bao, Y. Nomura, Y. Moon, Y. Tonozuka, Y. Minoshima, T. Hatori, A. Tsuchiya, M. Kiyono, T. Nosaka, H. Nakajima, D. A. Williams, and T. Kitamura. 2006. Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors. J. Cell Biol. 175:937-946.
37. Kazansky, A. V., E. B. Kabotyanski, S. L. Wyszomierski, M. A. Mancini, and J. M. Rosen. 1999. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J. Biol. Chem. 274:22484-22492.
38. Kumar, R., A. E. Gururaj, and C. J. Barnes. 2006. p21-activated kinases in cancer. Nat. Rev. Cancer 6:459-471.
39. Lernbecher, T., U. Müller, and T. Wirth. 1993. Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770.
40. Li, Z., X. Wang, R. Y. Yu, B. B. Ding, J. J. Yu, X. M. Dai, A. Naganuma, E. R. Stanley, and B. H. Ye. 2005. BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit. J. Immunol. 174:205-214.
41. Lin, Z., H. Kim, H. Park, Y. Kim, J. Cheon, and I. Kim. 2003. The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium. Urol. Res. 31:272-275.
42. Logarajah, S., P. Hunter, M. Kraman, D. Steele, S. Lakhani, L. Bobrow, A. Venkitaraman, and S. Wagner. 2003. BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene 22:5572-5578.
43. Matos, P., J. Collard, and P. Jordan. 2003. Tumour-related alternativespliced Rac1b is not regulated by Rho-GDI and exhibits selective downstream signalling. J. Biol. Chem. 278:50442-50448.
44. Matos, P., and P. Jordan. 2006. RAC1, but not RAC1B, stimulates RELB-mediated gene transcription in colorectal cancer cells. J. Biol. Chem. 281: 13724-13732.
45. Moorthy, A. K., O. V. Savinova, J. Q. Ho, V. Y. Wang, D. Vu, and G. Ghosh. 2006. The 20S proteasome processes NFkappaB1 p105 into p50 in a translation-independent manner. EMBO J. 25:1945-1956.
46. Niu, H., B. H. Ye, and R. Dalla-Favera. 1998. Antigen receptor signaling induces MAP kinase mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12:1953-1961.
47. Niu, H. 2002. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol. Oncol. 20:155-166.
48. Otaki, J. M., D. T. Fearon, and H. Yamamoto. 2005. The proto-oncogene BCL-6 is expressed in olfactory sensory neurons. Neurosci. Res. 53:189-200.
49. Park, E. J., K. A. Ji, S. B. Jeon, W. H. Choi, I. O. Han, H. J. You, J. H. Kim, I. Jou, and E. H. Joe. 2004. Rac1 contributes to maximal activation of STAT1 and STAT3 in IFN-gamma-stimulated rat astrocytes. J. Immunol. 173:5697-5703.
50. Phan, R. T., M. Saito, Y. Kitagawa, A. R. Means, and R. Dalla-Favera. 2007. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells. Nat. Immunol. 8:1132-1139.
51. Ponta, H., L. Sherman, and P. A. Herrlich. 2003. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4:33-45.
52. Rennefahrt, U. E., B. Illert, E. Kerkhoff, J. Troppmair, and U. R. Rapp. 2002. Constitutive JNK activation in NIH 3T3 fibroblasts induces a partially transformed phenotype. J. Biol. Chem. 277:29510-29518.
53. Ridley, A. J. 2001. Rho family proteins: coordinating cell responses. Trends Cell Biol. 11:471-477.
54. Ropponen, K. M., M. J. Eskelinen, P. K. Lipponen, E. Alhava, and V. M. Kosma. 1998. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand. J. Gastroenterol. 33:301-309.
55. Reference deleted.
56. Sakashita, C., T. Fukuda, S. Okabe, H. Kobayashi, S. Hirosawa, T. Tokuhisa, N. Miyasaka, O. Miura, and T. Miki. 2002. Cloning and characterization of the human BAZF gene, a homologue of the BCL6 oncogene. Biochem. Biophys. Res. Commun. 291:567-573.
57. Schuringa, J. J., L. V. Dekker, E. Vellenga, and W. Kruijer. 2001. Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase C delta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation. J. Biol. Chem. 276:27709-27715.
58. Sells, M. A., U. G. Knaus, S. Bagrodia, D. M. Ambrose, G. M. Bokoch, and J. Chernoff. 1997. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7:202-210.
59. Seyfert, V. L., D. Allman, Y. He, and L. M. Staudt. 1996. Transcriptional repression by the proto-oncogene BCL-6. Oncogene 12:2331-2342.
60. Shaffer, A. L., X. Yu, Y. He, J. Boldrick, E. P. Chan, and L. M. Staudt. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212.
61. Simon, A. R., H. G. Vikis, S. Stewart, B. L. Fanburg, B. H. Cochran, and K. Guan. 2000. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290:144-147.
62. Singh, A., A. E. Karnoub, T. R. Palmby, E. Lengyel, J. Sondek, and J. C. Der. 2004. Rac1b, a tumour associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23:9369-9380.
63. Solan, N. J., H. Miyoshi, E. M. Carmona, G. D. Bren, and C. V. Paya. 2002. RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 277:1405-1418.
64. Staudt, L. M., A. L. Dent, A. L. Shaffer, and X. Yu. 1999. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. Rev. Immunol. 18:381-403.
65. Sulciner, D. J., K. Irani, Z. X. Yu, V. J. Ferrans, P. Goldschmidt-Clermont, and T. Finkel. 1996. Rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-κB activation. Mol. Cell. Biol. 16:7115-7121.
66. Sundaresan, M., Z. X. Yu, V. J. Ferrans, D. J. Sulciner, J. S. Gutkind, K. Irani, P. J. Goldschmidt-Clermont, and T. Finkel. 1996. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 318: 379-382.
67. Tonozuka, Y., Y. Minoshima, Y. C. Bao, Y. Moon, Y. Tsubono, T. Hatori, H. Nakajima, T. Nosaka, T. Kawashima, and T. A. Kitamura. 2004. GTPaseactivating protein binds STAT3 and is required for IL-6-induced STAT3 activation and for differentiation of a leukemic cell line. Blood 104:3550-3557.
68. Wessells, J., M. Baer, H. A. Young, E. Claudio, K. Brown, U. Siebenlist, and P. F. Johnson. 2004. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J. Biol. Chem. 279: 49995-50003.
69. Wherlock, M., and M. Mellor. 2002. The Rho GTPase family: a Racs to Wrchs story. J. Cell Sci. 115:239-240.
70. Wielenga, V. J., K. H. Heider, G. J. Offerhaus, G. R. Adolf, F. M. van den Berg, H. Ponta, P. Herrlich, and S. T. Pals. 1993. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53:4754-4756.
71. Wielenga, V. J., R. Smits, V. Korinek, L. Smit, M. Kielman, R. Fodde, H. Clevers, and S. T. Pals. 1999. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol. 154:515-523.
72. Wu, W. S. 2006. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25:695-705.
73. Zhong, H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9:625-636.